Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic Lysergic Acid Diethylamide (LSD) derivative. BETR-001 mimics the projected therapeutic properties of LSD without causing its undesirable side effects such as hallucinations and cardiac toxicity. BETR-001 is a therapy to treat debilitating psychiatric disorders with high unmet need, such as major depressive disorder and anxiety disorders; as well as neurological disorders such as neuropathic pain. BETR-002 is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound for treatment of benzodiazepine dependency, anxiety and spasticity. The Company also owns a drug candidate for the treatment of viral infections such as COVID-19. The Company’s subsidiaries include MedMelior Inc., BetterLife Pharma US Inc. and Blife Therapeutics Inc.


CSE:BETR - Post by User

Comment by elgin1on Dec 23, 2020 5:12pm
153 Views
Post# 32174162

RE:RE:RE:this is a comedy show like no other

RE:RE:RE:this is a comedy show like no otherWagdaDog,

it will take at least $10 to $15 million US to do prelimary clinical trials for Fda application. Then it will have to be a multicenter site study that would cost at least another $25 million easily .

This of course would have to be backed by Institutional or pharma collaboration of some sort in my opinion . Yes it won't be overnight and take at least a few years .

Funny you mention the name "Lexi" for the cancer drug which was never publically released . So you seem to be a a disgruntled former board member possibly .

wagdadog .... Time will tell how the pipeline of Better Life products will fare. I am quite optimistic on the chances .  Why don't you come back in a few months and we can see the progress of the company ?

You must not be too far away in the country to get wifi to respond to this blog so In that case find a cell tower you can piss on. Just don't eat any yellow snow .

Elgin

<< Previous
Bullboard Posts
Next >>